Trump's drug policy linked to fewer launches in Europe

Drug launches in Europe have fallen by 27 per cent as Donald Trump pressures pharmaceutical companies to lower prices in the US, according to figures reported by The Wall Street Journal.

By Finwire

November 10, 2026 10:03 AM

1 month free trial

Get access to all content on Life Science Focus

No commitment or card information required

Try Life Science Focus now

Already a subscriber? Log In

Applies to personal subscription only.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.

Yes please, I would like to receive Life Science Focuss newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Focus Read cookie and data policy.

Life Science Focus Breaking/Extra

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}

Trump's drug policy linked to fewer launches in Europe

FDA approves Bayer’s first-in-class stroke drug

From IV drips to injection pens: Why more drugs can be given under the skin

Danish biotech company raises €20 million: Closing in on clinical trials

Trump's drug policy linked to fewer launches in Europe

30 Years of Connecting Medicon Valley

Autoinjectors gain ground across therapeutic areas: “A huge trend”

Cavidi’s BOLD Named “Proteomics Innovation of the Year” as US Patent Nears Grant

Process equipment for biotechnology and pharmaceutical production

3PL- där kvalitet aldrig kompromissas

UK plans permanent recognition of CE-marked medical devices

Rätt ledare för rätt kabelapplikation

Upcoming Course: Internal Audits Based on ISO 13485 for Medtech Organizations

Gruber delivers technology for demanding production environments

From legacy devices to software IVDs: Medtech Compliance Forum puts the spotlight on IVDR compliance

Rätt ventil för rätt applikation – hitta lösningen hos OEM Automatic

Structured Dialogue with SGS Fimko – a clearer path through MDR and IVDR

GRUBER aims to eliminate bottlenecks in pharmaceutical production

What if some of the most influential systems in healthcare are the least regulated?